Heat Biologics Secures $5,050,050 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b6e1b6c-4383-45bf-b8b3-352742e81e4d -
Date
4/10/2013 -
Company Name
Heat Biologics -
Mailing Address
100 Europa Drive Chapel Hill, NC 27517 USA -
Company Description
Heat Biologics (Heat) is a clinical-stage company focused on the development and commercialization of its HS-System, a platform technology that offers a novel approach to treating cancer and other diseases by using live, modified cell lines to activate the immune system against specific defined targets. -
Website
http://www.heatbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,050,050 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
